Prevalence of Vitamin D Deficiency and the Effect of Vitamin D3 Supplementation on Response to Anti-Tuberculosis Therapy in Patients with Extrapulmonary Tuberculosis
ABSTRACT
We conducted a study to measure serum vitamin D levels in patients with extrapulmonary tuberculosis (EPTB) and to assess the impact of vitamin D3 supplementation on their treatment.
In our study, we found that all EPTB patients had vitamin D deficiency, with significantly lower vitamin D levels compared to healthy controls. Patients who received vitamin D3 supplementation in addition to anti-TB drugs showed improvements in weight gain, serum albumin levels, hemoglobin concentration, and inflammatory markers. Additionally, those with TB pleurisy experienced a higher rate of pleural fluid resolution and shorter treatment duration.
Our findings suggest that vitamin D supplementation is a beneficial adjunctive therapy to anti-TB drugs for EPTB patients.
Clinical Trials and Practical Solutions
Clinical trials play a crucial role in developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians, helping to extend the benefits of clinical trials into everyday medical practice.
Value of Streamlining Operations in Healthcare
In today’s healthcare environment, streamlining operations is essential. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally. By leveraging AI, clinics can enhance their workflows, improve patient outcomes, and reduce paper routines.
Learn more about how we can help at aidevmd.com.
